| Product NDC: | 0068-0509 |
| Proprietary Name: | Rifamate |
| Non Proprietary Name: | rifampin and isoniazid |
| Active Ingredient(s): | 150; 300 mg/1; mg/1 & nbsp; rifampin and isoniazid |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0068-0509 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA061884 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19750711 |
| Package NDC: | 0068-0509-60 |
| Package Description: | 60 CAPSULE in 1 BOTTLE (0068-0509-60) |
| NDC Code | 0068-0509-60 |
| Proprietary Name | Rifamate |
| Package Description | 60 CAPSULE in 1 BOTTLE (0068-0509-60) |
| Product NDC | 0068-0509 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rifampin and isoniazid |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19750711 |
| Marketing Category Name | ANDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | ISONIAZID; RIFAMPIN |
| Strength Number | 150; 300 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient],Antimycobacterial [EPC] |